Cell & Gene Therapy: Transformative Potential, Practical Challenges
Cell and gene therapies (CGT) represent a paradigm shift in medicine — offering the promise of durable, and in some cases curative, treatments for cancer, genetic disorders, and other previously intractable diseases. By modifying cellular or genetic components directly, CGT allows for highly personalized and targeted therapeutic approaches.
Yet despite its promise, the path from discovery to clinical application is challenged by technical hurdles such as efficient gene delivery, vector optimization, immune response assessment, and the reproducibility of functional assays — all of which are critical during the early stages of therapeutic development.
ImmunitasBio: Empowering the Discovery of Tomorrow’s Therapies
At ImmunitasBio Pvt. Ltd., we provide cutting-edge research services to support biotech and pharmaceutical innovators developing CAR-T cells, gene therapies, and next-generation delivery platforms. Based in India, we bring global quality with regional accessibility—delivering precision, speed, and scientific depth to accelerate your preclinical R&D. We offer a focused portfolio of services to support the preclinical development of gene-modified therapies, including CAR-T cell products, viral vector platforms, and nucleic acid delivery systems. Our capabilities are designed to help you generate high-quality, data-driven insights that guide therapeutic design and optimization.
We offer a uniquely integrated portfolio of preclinical services that span from viral vector engineering and functional bioassays to immune cell manipulation and nanomaterial-based delivery system characterisation, providing a single-source solution for complex R&D workflows.
Why Work With Us
- Focused on non-clinical applications: all services are for RUO only
- Extensive experience in gene therapy, cell-based assays, and immune analysis
- Expertise in producing high-quality primary human cells (PBMCs)
- Rapid project initiation and collaborative protocol development
- Based in India with global reach and cost-effective R&D execution
Let’s Collaborate
If you’re engineering a new CAR construct, evaluating a gene delivery platform, or validating a novel immunomodulator, we can help generate the critical data you need to move forward. Contact us to discuss your specific project requirements
Our Cells and Gene Technology Service
Lentiviral Vector Development
CAR-T Production
Functional Assessments
LNP Development
Immune Assays & Biomarker
Custom Assay Development